Argent Capital Management’s Haemonetics HAE Stock Holding History

Argent Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-61,300	Closed	-$2M	–	154
2014 Q1	$2M	Buy	61,300 +19,625	+47%	+$750K	0.11%	106
2013 Q4	$1.76M	Buy	+41,675	New	+$1.71M	0.1%	110

Other funds holding HAE

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Argent Capital Management's HAE Position: Q2 2014 in Review

Argent Capital Management sold out of Haemonetics (HAE) in Q2 2014, closing a stake of 61,300 shares — an estimated $2M sold.

Argent Capital Management first reported a position in HAE in Q4 2013 and held it in 2 quarters. The position peaked at $2M in Q1 2014. 175 funds tracked by Wall St. Rank hold HAE as of Q2 2014.

Argent Capital Management reported no remaining Haemonetics position as of Q2 2014 after selling out during the quarter.
Argent Capital Management sold 61,300 Haemonetics shares in Q2 2014, an estimated $2M.
Argent Capital Management first reported a position in Haemonetics in Q4 2013 and held it in 2 quarters.
Argent Capital Management's Haemonetics position peaked at $2M in Q1 2014.
175 funds tracked by Wall St. Rank held Haemonetics as of Q2 2014.

Based on Argent Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.